Coherus BioSciences, Inc. - COM (CHRS)

Historical Portfolio Holders from Q4 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
81.7M
Holdings value Q2 2024
$141M
Value change Q2 2024
-$432K
Grand Portfolio weight change Q2 2024
0%
Number of holders
131
Number of buys Q2 2024
9
Number of sells Q2 2024
-10
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 3.02M $3.13M -$150K $1.04 25
2024 Q2 81.7M $141M -$432K $1.73 132
2024 Q1 81.6M $195M -$7.51M $2.39 132
2023 Q4 81.3M $271M -$38M $3.33 154
2023 Q3 92.9M $348M +$14.5M $3.74 167
2023 Q2 86.7M $370M +$30.6M $4.27 160
2023 Q1 78.4M $536M -$2.03M $6.84 166
2022 Q4 78.6M $622M +$4.1M $7.92 161
2022 Q3 77.4M $743M -$14.9M $9.61 167
2022 Q2 78.9M $572M +$19.3M $7.24 171
2022 Q1 75.4M $973M -$15.1M $12.91 171
2021 Q4 75.9M $1.21B +$9.15M $15.96 190
2021 Q3 75.3M $1.21B -$23.9M $16.07 182
2021 Q2 77M $1.07B -$38.4M $13.83 185
2021 Q1 79.4M $1.16B -$125M $14.61 202
2020 Q4 86.7M $1.51B +$7.07M $17.38 190
2020 Q3 87.9M $1.61B -$16.5M $18.34 201
2020 Q2 86.5M $1.54B +$229M $17.86 188
2020 Q1 74.5M $1.21B +$27.8M $16.22 186
2019 Q4 72.6M $1.31B +$50.5M $18.00 185
2019 Q3 69.2M $1.4B +$54.9M $20.26 165
2019 Q2 66.6M $1.47B +$26M $22.10 144
2019 Q1 68.7M $938M +$44.2M $13.64 115
2018 Q4 65.7M $594M -$13.9M $9.05 107
2018 Q3 63.6M $1.05B +$28.5M $16.50 108
2018 Q2 62M $867M +$96.2M $14.00 115
2018 Q1 55.3M $611M +$32.9M $11.05 103
2017 Q4 49.5M $435M +$17.2M $8.80 94
2017 Q3 46.9M $627M +$87.2M $13.35 90
2017 Q2 40.1M $576M +$26.8M $14.35 105
2017 Q1 37.3M $789M +$211M $21.15 108
2016 Q4 29.9M $842M +$50.9M $28.15 121
2016 Q3 27.8M $743M +$77M $26.78 115
2016 Q2 25.3M $428M +$112M $16.89 85
2016 Q1 18.2M $387M +$29.1M $21.23 74
2015 Q4 16.7M $384M +$8.77M $22.96 77
2015 Q3 15.8M $317M +$14.2M $20.04 76
2015 Q2 14.9M $431M +$223M $28.90 71
2015 Q1 7.27M $222M -$28.1M $30.58 49
2014 Q4 9.85M $158M +$158M $16.32 37